SOURCE: Xtalks

Xtalks Webinars

July 29, 2015 07:00 ET

Evidence in Action -- Uses of Real World Evidence Throughout the Drug Development Continuum, New Webinar Presented by Xtalks

TORONTO, ON--(Marketwired - July 29, 2015) - Join featured speaker, Dr. Tommy Bramley, Senior Vice President of Scientific Consulting at Xcenda, for a complimentary webinar focusing on successful uses of real world evidence throughout the development process. This session will explore the impact of data in proving product value and its strategic use to help guide future development plans. The live broadcast takes place on Tuesday, August 18, 2015 at 1pm EDT.

With the continuing demand for economic and clinical evidence to differentiate innovative therapies from existing agents, manufacturers need to take advantage of real world evidence earlier to make strategic decisions during the development process.

Learn how various data and methods have been used to uncover information that can be strategically relevant and beneficial for the success of a manufacturer's product.

Dr. Bramley will discuss practical examples of how this can work:

  • Characterize the target patient population and evaluate how employing different inclusion / exclusion criteria may impact the population size, as well as the number of patients eligible for inclusion in randomized clinical trials (RCTs)
  • Describe current real world treatment patterns and outcomes to inform selection of RCT comparators, endpoints and targeted line(s) of therapy
  • Test product attributes relative to current standard of care to assess potential value and identify key value drivers
  • Estimate how target patient population(s) may change over time based on patient demographics and the introduction of other interventions

To learn more or register for this event visit: Evidence in Action -- Uses of Real World Evidence Throughout the Drug Development Continuum

About Xcenda
Xcenda is a strategic consulting firm with more than 20 years of experience applying real-world expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy. As part of AmerisourceBergen Corporation, a leading global healthcare solutions company, Xcenda supports global pharmaceutical companies as well as emerging pre-commercialization phase firms with challenges such as developing an evidence package to optimize access in key global markets, predicting product performance, and identifying reimbursement strategies and programs to maximize patient access. From development through market maturity, Xcenda helps manufacturers identify, demonstrate, and deliver their brand's value proposition to key healthcare stakeholders. For more information visit http://www.xcenda.com/.

About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/7/28/11G048992/Images/Xcenda_CMYK_(1)-301466508781.JPG

Contact Information